Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2005
10/20/2005WO2005097116A1 Composition comprising a jnk inhibitor and cyclosporin
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005058845A3 Novel glucagon antagonists/inverse agonists
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005051931A3 Phosphodiesterase inhibitors
10/20/2005WO2005046590A3 Methods for synthesizing quinolinone compounds
10/20/2005WO2005034857A3 Methods and compositions comprising diamines as new anti-tubercular therapeutics
10/20/2005WO2003106413A3 Process for the preparation of oxazolidinones and method of use thereof
10/20/2005US20050234247 New effector conjugates, process for their production and their pharmaceutical use
10/20/2005US20050234238 8-(Biaryl)quinoline pde4 inhibitors
10/20/2005US20050234116 e.g. 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-[3-(2-methylphenoxy)propyl]oxazole; voltage-dependent anion channel, mitochondria porin modulator, apoptosis suppressor, mitochondria function ameliorator; Down syndrome, pigmentary degeneration of retina, alcoholic hepatitis or sideroblastic anemia
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234102 Inhibiting the proteolytic activity of cathepsin S, comprising exposing cathepsin S to compounds such as 1-[4-(5-Chloro-1H-indol-3-yl)-piperidin-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol
10/20/2005US20050234083 Diamino-pyrimidines and their use as angiogenesis inhibitors
10/20/2005US20050234082 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/20/2005US20050234081 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals
10/20/2005US20050234080 Mitotic kinesin inhibitors
10/20/2005US20050234072 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life
10/20/2005US20050234064 2-(4-Methoxyphenyl)-amino-),3-(aminocarbonyl-)quinoxaline; janus(JAK) kinase inhibitors;spleen tyrosine kinase(SYK) inhibitors; glycogen synthase-3(GSK-3) kinase inhibitors; immunocompetance; antiinflammatory agents; antiallergens; autoimmune diseases; antiproliferative agents; respiratory disorders
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234057 1-Phenylpiperidin-3-one derivatives and processes for the preparation thereof
10/20/2005US20050234055 Pyrazole derivative
10/20/2005US20050234049 Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds
10/20/2005US20050234048 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease
10/20/2005US20050234047 Respiratory syncytial virus replication inhibitors
10/20/2005US20050234044 Cyclic amine derivatives and methods of use
10/20/2005US20050234042 Organic compounds
10/20/2005US20050234041 Substituted 1-benzazepines and derivatives thereof
10/20/2005US20050234030 Modulators of CRTH2, COX-2 and FAAH
10/20/2005US20050233909 such as 6-(5-chlorobenzoxazol-2-yl)-2-(3-trifluoromethylphenoxy)pyridine, used on monocotyledonus or dicotyledonus weeds
10/20/2005CA2567574A1 Benzotriazine inhibitors of kinases
10/20/2005CA2562780A1 Nucleic acid melting analysis with saturation dyes
10/20/2005CA2562140A1 Phenylthioacetic acid derivatives and use thereof
10/20/2005CA2561967A1 Substituted 4-alkyl- and 4-alkanoyl-piperidine derivatives and their use as neurokinin antagonists
10/20/2005CA2561907A1 Composition comprising a jnk inhibitor and cyclosporin
10/20/2005CA2561801A1 Sulfonamides and uses thereof
10/20/2005CA2561791A1 Non-imidazole heterocyclic compounds
10/20/2005CA2561738A1 1,3,4-oxadiazol-2-ones as ppar delta modulators_and their use thereof
10/20/2005CA2561627A1 Oxadiazolone derivatives as ppar delta agonists
10/20/2005CA2561280A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005CA2561230A1 1,3,4-oxadiazol-2-ones as ppar delta modulators and their use thereof
10/20/2005CA2561206A1 Novel diazine derivatives, their manufacture and use as pharmaceutical agents
10/20/2005CA2561203A1 New process for the preparation of diazine derivatives
10/20/2005CA2560796A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005CA2560162A1 Inhibitors of iap
10/20/2005CA2559866A1 Anaplastic lymphoma kinase modulators and methods of use
10/19/2005EP1586573A1 Oxadiazolones, processes for their preparation and their use as pharmaceuticals
10/19/2005EP1586567A1 Compounds useful in the treatment of inflammatory diseases
10/19/2005EP1586565A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
10/19/2005EP1586564A1 8-azaprostaglandin derivatives and medicinal uses thereof
10/19/2005EP1585827A2 Modulation of protein functionalities
10/19/2005EP1585737A2 Uracils having a herbicidal activity
10/19/2005EP1585734A2 Anti-inflammatory medicaments
10/19/2005EP1585727A1 Indoles useful in the treatment of androgen-receptor related diseases
10/19/2005EP1585726A1 Fused heterocyclic derivatives as ppar modulators
10/19/2005EP1585725A2 Compounds which mimic the chemical and biological properties of discodermolide
10/19/2005EP1585541A2 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1585518A2 Peptide deformylase inhibitors
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1370554B1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
10/19/2005EP1210344B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/19/2005CN1685014A Metal complexes as light-absorbing compounds in the information layer of optical data carriers
10/19/2005CN1685008A Synergistic UV absorber combination
10/19/2005CN1684960A Delta1 pyrrolines used as pesticides
10/19/2005CN1684957A Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors
10/19/2005CN1683370A Hetaryl-substd. heterocycles
10/19/2005CN1683344A 4-quinazolone derivative and its use in anti-tumor medicine
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/19/2005CN1223348C N-(aryloxy group alkyl) heteroaromatic guadine and heteroaromatic guazine used as medicines
10/18/2005US6956052 treatment of cancer and inflammation-associated disorders, such as arthritis; for example,1-[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide
10/18/2005US6956040 Oxazolidinone piperazinyl derivatives as potential antimicrobials
10/18/2005US6956036 6-hydroxy-indazole derivatives for treating glaucoma
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005CA2329075C Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists
10/18/2005CA2295063C Indole compounds as anti-inflammatory/analgesic agents
10/18/2005CA2190129C Therapeutic phenoxyalkylpyridazines and intermediates therefor
10/18/2005CA2125730C Novel sulfonylamino pyrimidines
10/13/2005WO2005095440A1 BETA-AMINOACID-DERIVATIVES AS FACTOR Xa INHIBITORS
10/13/2005WO2005095409A2 Tetrahydroquinoline derivatives and a process for preparing the same
10/13/2005WO2005095393A1 Oxidized thioether derivatives of styryl-azoles and their use as her tyrosine kinases inhibitors
10/13/2005WO2005095389A1 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient
10/13/2005WO2005095388A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
10/13/2005WO2005095387A1 Tricyclic pyrazole kinase inhibitors
10/13/2005WO2005095386A1 Substituted thiophene derivatives as anti-cancer agents
10/13/2005WO2005095384A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/13/2005WO2005095382A1 Anti-tumor agent
10/13/2005WO2005095380A1 Cyclic amine compound and pest control agent
10/13/2005WO2005095366A1 7-aryl 1,5-dihydro-4,1-benzoxazepin-2(3h)-one derivatives and their use as progesterone receptor modulators
10/13/2005WO2005095364A1 Phenoxyacetic acid derivative and medicine containing the same
10/13/2005WO2005095363A1 Bicyclic compound and medicine containing the same
10/13/2005WO2005095361A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095360A1 Neurologically-active compounds
10/13/2005WO2005095359A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
10/13/2005WO2005095357A2 Pyrimidine derivatives and methods of treatment related to the use thereof
10/13/2005WO2005095352A1 Process for producing 5-hydroxy-4-thiomethylpyrazole compound
10/13/2005WO2005095350A1 Pyrazole compounds and uses related thereto
10/13/2005WO2005095346A1 3-((hetero)arylsulfonyl)-8-` (aminoalkyl)oxy!quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
10/13/2005WO2005094828A1 4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
10/13/2005WO2005094805A1 Imine derivative and amide derivative
1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 647